|
1
|
Oksenhendler E, Boutboul D, Fajgenbaum D,
Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard
L and Galicier L: The full spectrum of Castleman disease: 273
patients studied over 20 years. Br J Haematol. 180:206–216.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Biçakçioğlu P, Gülhan SS, Acar LN,
Ağaçkiran Y, Özkara Ş, Kaya S and Karaoğlanoğlu N: Intrathoracic
Castleman disease. Turk J Med Sci. 44:197–202. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dispenzieri A and Fajgenbaum DC: Overview
of Castleman disease. Blood. 135:1353–1364. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Haap M, Wiefels J, Horger M, Hoyer A and
Müssig K: Clinical, laboratory and imaging findings in Castleman's
disease-The subtype decides. Blood Rev. 32:225–234. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
van Rhee F, Oksenhendler E, Srkalovic G,
Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S,
Streetly M, et al: International evidence-based consensus
diagnostic and treatment guidelines for unicentric Castleman
disease. Blood Adv. 4:6039–6050. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kligerman SJ, Auerbach A, Franks TJ,
Franks TJ and Galvin JR: Castleman disease of the thorax: Clinical,
radiologic, and pathologic correlation: From the radiologic
pathology archives. Radiographics. 36:1309–1332. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang X, Rao H, Xu X, Li Z, Liao B, Wu H,
Li M, Tong X, Li J and Cai Q: Clinical characteristics and outcomes
of Castleman disease: A multicenter study of 185 Chinese patients.
Cancer Sci. 109:199–206. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hill AJ, Tirumani SH, Rosenthal MH,
Shinagare AB, Carrasco RD, Munshi NC, Ramaiya NH and Howard SA:
Multimodality imaging and clinical features in Castleman disease:
Single institute experience in 30 patients. Br J Radiol.
88(20140670)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ota H, Kawai H and Matsuo T: Unicentric
castleman's disease arising from an intrapulmonary lymph node. Case
Rep Surg. 2013(289089)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sarana B, Jaal J, Tamm H and Laisaar T:
Resection of unicentric interlobar Castleman disease with following
adjuvant radiotherapy. SAGE Open Med Case Rep.
5(2050313x17744481)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mimouni D, Anhalt GJ, Lazarova Z, Aho S,
Kazerounian S, Kouba DJ, Mascaro JM Jr and Nousari HC:
Paraneoplastic pemphigus in children and adolescents. Br J
Dermatol. 147:725–732. 2002.PubMed/NCBI View Article : Google Scholar
|
|
12
|
van Rhee F and Munshi NC: Castleman
disease. Hematol Oncol Clin North Am. 32:xiii–xiv. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Boutboul D, Fadlallah J, Chawki S, Fieschi
C, Malphettes M, Dossier A, Gérard L, Mordant P, Meignin V,
Oksenhendler E and Galicier L: Treatment and outcome of unicentric
castleman disease: A retrospective analysis of 71 cases. Br J
Haematol. 186:269–273. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Larroche C, Cacoub P, Soulier J,
Oksenhendler E, Clauvel JP, Piette JC and Raphael M: Castleman's
disease and lymphoma: Report of eight cases in HIV-negative
patients and literature review. Am J Hematol. 69:119–126.
2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang ST, Wang QP, Li J, Zhang T, Zhang L
and Mao YY: Amyloidosis secondary to intrapulmonary Castleman
disease mimicking pulmonary hyalinizing granuloma-like clinical
features: A rare case report. Medicine (Baltimore).
98(e15039)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang H, Zhang JQ, Zhong XN, Liu GN, Li
MH, Bai J, He ZY and Deng JM: Two case reports of Castleman disease
with pulmonary involvement. Int J Tuberc Lung Dis. 19:362–365.
2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hwangbo Y, Cha SI, Lee YH, Lee SY, Seo H,
Oh S, Kim M, Choi SH, Park TI and Shin KM: A case of multicentric
castleman's disease presenting with follicular bronchiolitis.
Tuberc Respir Dis (Seoul). 74:23–27. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nabeya D, Yoshimatsu Y and Fujiwara H: A
case of acute progressive diffuse interstitial lung disease
preceding idiopathic multicentric Castleman disease. Respir Med
Case Rep. 31(101216)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Johkoh T, Müller NL, Ichikado K, Nishimoto
N, Yoshizaki K, Honda O, Tomiyama N, Naitoh H, Nakamura H and
Yamamoto S: Intrathoracic multicentric Castleman disease: CT
findings in 12 patients. Radiology. 209:477–481. 1998.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Herrada J, Cabanillas F, Rice L, Manning J
and Pugh W: The clinical behavior of localized and multicentric
Castleman disease. Ann Intern Med. 128:657–662. 1998.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chronowski GM, Ha CS, Wilder RB,
Cabanillas F, Manning J and Cox JD: Treatment of unicentric and
multicentric Castleman disease and the role of radiotherapy.
Cancer. 92:670–676. 2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Marcelin AG, Aaron L, Mateus C, Gyan E,
Gorin I, Viard JP, Calvez V and Dupin N: Rituximab therapy for
HIV-associated Castleman disease. Blood. 102:2786–2788.
2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ide M, Kawachi Y, Izumi Y, Kasagi K and
Ogino T: Long-term remission in HIV-negative patients with
multicentric Castleman's disease using rituximab. Eur J Haematol.
76:119–123. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ocio EM, Sanchez-Guijo FM, Diez-Campelo M,
Castilla C, Blanco OJ, Caballero D and San Miguel JF: Efficacy of
rituximab in an aggressive form of multicentric Castleman disease
associated with immune phenomena. Am J Hematol. 78:302–325.
2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Corbellino M, Bestetti G, Scalamogna C,
Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M,
Galli M and Parravicini C: Long-term remission of Kaposi
sarcoma-associated herpesvirus-related multicentric Castleman
disease with anti-CD20 monoclonal antibody therapy. Blood.
98:3473–3475. 2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kofteridis DP, Tzagarakis N, Mixaki I,
Maganas E, Xilouri E, Stathopoulos EN, Eliopoulos GD and Gikas A:
Multicentric Castleman's disease: Prolonged remission with anti
CD-20 monoclonal antibody in an HIV-infected patient. AIDS.
18:585–586. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bower M, Newsom-Davis T, Naresh K,
Merchant S, Lee B, Gazzard B, Stebbing J and Nelson M: Clinical
features and outcome in HIV-Associated multicentric castleman's
disease. J Clin Oncol. 29:2481–2486. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Anhalt GJ: Paraneoplastic pemphigus. J
Investig Dermatol Symp Proc. 9:29–33. 2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lim JM, Lee SE, Seo J, Kim DY, Hashimoto T
and Kim SC: Paraneoplastic pemphigus associated with a malignant
thymoma: A case of persistent and refractory oral ulcerations
following thymectomy. Ann Dermatol. 29:219–222. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang L, Bu D, Yang Y, Chen X and Zhu X:
Castleman's tumours and production of autoantibody in
paraneoplastic pemphigus. Lancet. 363:525–531. 2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Reichard KK, Robinett S and Foucar MK:
Clonal cytogenetic abnormalities in the plasma cell variant of
Castleman disease. Cancer Genet. 204:323–327. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mihara M, Hashizume M, Yoshida H, Suzuki M
and Shiina M: IL-6/IL-6 receptor system and its role in
physiological and pathological conditions. Clin Sci (Lond).
122:143–159. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Luo JM, Li S, Huang H, Cao J, Xu K, Bi YL,
Feng RE, Huang C, Qin YZ, Xu ZJ and Xiao Y: Clinical spectrum of
intrathoracic Castleman disease: A retrospective analysis of 48
cases in a single Chinese hospital. BMC Pulm Med.
15(34)2015.PubMed/NCBI View Article : Google Scholar
|
